OleaXin™ Oleanolic Acid Nanogel

 

PURIPHARM CO., LTD. · PuriActives® High-Performance Actives

OleaXin™ Oleanolic Acid Nanogel

齐肤因™ · Oleanolic Acid Nanogel

From a high-potential pentacyclic triterpene to a modern Nanogel active system.

INCI: Oleanolic Acid · Phospholipids · Glycerin · Water

Technical Marketing Presentation · For B2B Professional Use Only

01 · THE OPPORTUNITY

Why Refocus on Oleanolic Acid?

01 A Multi-Target Biological Foundation

Sebum regulation · inflammatory signaling · oxidative stress · ECM homeostasis · follicular microenvironment. Oleanolic acid is a pentacyclic triterpene widely found in olive, Ligustrum lucidum, and other plants, long followed by dermatological literature. Its value lies not in a single benefit, but in simultaneously touching multiple biological pathways related to oily skin, blemish-prone skin, and scalp health.

02 Skin + Scalp Dual Scenarios

Facial oil control and soothing share one mechanistic framework with scalp oil management.

03 A Deep Literature and Patent Base

From enzymology and cell studies to animal and human research, the evidence chain spans more than two decades.

04 Aligned with Oily-Skin and Scalp-Care Trends

Blemish-prone skin management, scalp microbiome care, and the “skinification” of hair care continue to gain momentum.

The scientific potential is high, yet formulation use is anything but simple — its highly lipophilic molecular nature has kept oleanolic acid a “research hotspot” rather than a “formulation regular.”

02 · MOLECULAR IDENTITY

Meet Oleanolic Acid: A Classic Pentacyclic Triterpene

Naming note: “石竹素” is the Chinese inventory name of Oleanolic Acid in China’s cosmetic ingredient system; the scientific narrative uses “齐墩果酸” (oleanolic acid), the name familiar to R&D professionals. Official ingredient information follows the INCI name.

INCI name Oleanolic Acid
Chinese inventory name 石竹素 (Inventory of Existing Cosmetic Ingredients in China)
CAS number 508-02-1
Formula / MW C₃₀H₄₈O₃ / 456.70 g·mol⁻¹
Chemical class Pentacyclic triterpene (β-amyrin type)
Natural sources Olive leaves, Ligustrum lucidum, Centella asiatica, and other plants
Physicochemical profile Highly lipophilic; practically insoluble in water

A molecule studied for over half a century — as one of the active components of many medicinal plants, its anti-inflammatory, antioxidant, and metabolism-modulating activities have been repeatedly reported in pharmacological literature, and its skin and scalp biology value continues to be rediscovered.

References: Ayeleso TB et al. Molecules. 2017;22(11):1915. DOI:10.3390/molecules22111915; PubChem CID 10494.

03 · THE FORMULATION CHALLENGE

High Bioactivity Does Not Mean High Formulation Usability

Practical Impact for Formulators

Difficult to dose directly into water-based serums and gels, requiring pre-dissolving or solubilization design; crystallization causes non-uniform content, affecting batch stability and efficacy consistency; high-ethanol / high-oil solubilization limits sensory feel and dosage-form options; the active’s theoretical efficacy is hard to convert reliably into finished-product performance.

The Industry Recognized This Long Ago

As early as 2001, an international cosmetics group filed a patent around “solubilizing pentacyclic triterpenic acids” (US 2001/0029266 A1), improving dispersion through specific emulsifier systems. Review literature likewise notes that oleanolic acid’s low water solubility limits its bioavailability, with structural modification and delivery systems as the two solution paths.

Solving the formulation bottleneck matters more than discovering yet another benefit — this is exactly where OleaXin™ starts.

References: US 2001/0029266 A1; Wang W et al. Curr Top Med Chem. 2022;22(1). DOI:10.2174/1568026621666211105101231.

04 · THE SOLUTION

PuriActives® OleaXin™ — Rebuilding Oleanolic Acid as a Nanogel

OleaXin™ converts highly lipophilic oleanolic acid, through phospholipid association and nanostructured dispersion, into a Nanogel active format compatible with aqueous systems — without changing the molecule itself, only the way it exists in a formula.

INCI NAMEOleanolic Acid 石竹素Phospholipids 磷脂 · Glycerin 甘油 · Water 水 DESIGN LOGICOleanolic acid + phospholipids + glycerin + water→ Nanogel Delivery System
a. Nanostructured deliveryNanostructured presentation of a lipophilic active b. Aqueous compatibilityAqueous-compatible format for modern chassis
c. Formulation-friendly dispersionImproved dispersion, fewer pre-dissolving steps d. Skin & scalp versatilityOne active for both skin and scalp care

齐肤因™ is the Chinese product name of PuriActives® OleaXin™. This material is for cosmetic ingredient technical exchange only and involves no pharmaceutical claims.

05 · DELIVERY ENGINEERING

From Crystalline Active to Nanogel: An Engineered Pathway

What It Means at the Formulation Level

· Improved aqueous dispersion · Lower crystallization risk · Simpler pre-dissolving · Broader dosage-form options · Better formula uniformity

Core conversion logic: Hard-to-Formulate Bioactive ——→ Ready-to-Use Advanced Active

Technical note: this page illustrates the delivery system design principle. OleaXin™’s specific particle size, encapsulation efficiency, and penetration data are subject to measured values in the PuriPharm TDS; without cited measured data, this material does not use statements such as “penetration increased by XX%.”

06 · BIOLOGICAL LANDSCAPE

One Active, Multiple Skin and Scalp Biology Pathways

The pentacyclic triterpene scaffold determines oleanolic acid’s potential to interact with multiple cellular signaling pathways. The following chapters unfold in the order of mechanism → data → biological significance → cosmetic value, each pathway annotated with traceable literature or patent evidence and its evidence level.

07 · SEBUM REGULATION

Oil Balance: Starting from Sebaceous Gland Biology

Sebum secretion is governed by androgen signaling: testosterone is converted by 5α-reductase into the more potent DHT, driving sebaceous gland hyperplasia and lipid synthesis. 5α-reductase is therefore a classic target for oil-control actives.

Human Efficacy Reference: An Oleanolic Acid-Containing Blend

28-day half-face controlled use test (3% blend, n≈20, oily-skin panel); multi-ingredient system, not attributable to oleanolic acid alone.

-21.7%skin gloss (mean) -16%pore surface area (mean) -32%sebum flow (mean)

Reading the Evidence

· Oleanolic acid’s 5α-reductase inhibition is direct in-vitro enzymatic evidence (patent assay data);· The human data come from a multi-ingredient blend containing oleanolic acid, indicating the mechanism’s market translation value;· Sebum management should also address inflammation and oxidative stress (next page).

Data sources: US 7,182,963 B2 (in-vitro 5α-reductase enzymatic assay); attached technical documentation (28-day human test of an oleanolic acid-containing blend).

08 · BLEMISH-PRONE SKIN

Blemish-Prone Skin Is Not a Single-Pathway Problem

Blemish formation involves the interplay of excess sebum, abnormal follicular duct keratinization, the microbial environment, and inflammatory responses. Oleanolic acid’s value lies in evidence covering several of these links — not merely “antibacterial anti-acne.”

① Sebum secretion5α-reductase / androgen-driven lipid synthesis ② Follicular environmentDuct keratinization and sebum retention form the comedone microenvironment ③ Microbial factorsCutibacterium acnes-related flora environment ④ Inflammatory responseNF-κB-driven redness and discomfort

Where Oleanolic Acid’s Evidence Sits in Each Link

■ Sebum link Concentration-dependent 5α-reductase inhibition (56.3% at 0.1%, in-vitro enzymatic assay)■ Microbial link Patent literature reports inhibitory activity against C. acnes and other skin-related flora■ Inflammation link Modulates NF-κB / STAT1 signaling in keratinocytes and animal models (detailed next page)■ Barrier link Promotes epidermal differentiation and barrier recovery, helping blemish-prone skin maintain a more stable state

Translated into Cosmetic Language

· Oily and blemish-prone skin care · Sebum balance management · Pore oil-environment management · Soothing discomfort of blemish-prone skinNo pharmaceutical claims such as “treating acne”; mechanistic evidence supports the product’s scientific narrative.

References: US 7,182,963 B2; Kang YM et al. Int J Mol Sci. 2021;22:12000; Lim SW et al. J Dermatol. 2007;34:625-634.

09 · INFLAMMATORY BALANCE

Stabilizing Stressed Skin from the Source of Inflammatory Signaling

Mechanistic Evidence: Cell and Animal Levels Corroborate Each Other

In vitro (HaCaT keratinocytes) Under TNF-α / IFN-γ stimulation, oleanolic acid blocked the activation of Akt, NF-κB, and STAT1, and suppressed Th2-type cytokine and chemokine expression.

In vivo (DNCB mouse model) Three weeks of topical dosing significantly relieved dermatitis-like lesions, reducing epidermal/dermal thickness, mast cell infiltration, and serum histamine levels.

Cosmetic value Helps soothe irritated skin · Maintains a healthy inflammatory balance · Improves skin comfort under stressful environments

Data source: Kang YM et al. Int J Mol Sci. 2021;22(21):12000. DOI:10.3390/ijms222112000 (animal and cell evidence, not human clinical conclusions).

10 · OXIDATIVE STRESS DEFENSE

Helping Skin Build Stronger Stress Defense

An Honest Scientific Positioning: It Is Not a Classic “Antioxidant”

DPPH radical-scavenging assays show oleanolic acid’s direct scavenging capacity is weak (only 9.2% at 100 µM, roughly equivalent to 4.45 µM Trolox). Its value lies in another path: pharmacological research links the oleanolic acid scaffold to the Keap1 / Nrf2 endogenous defense system and downstream antioxidant enzymes (HO-1, NQO-1), and it reduces oxidative stress markers in inflammation models.

Cell Compatibility: Evidence in Human Skin Fibroblasts

24-hour cytotoxicity assay: oleanolic acid (OA) showed no cytotoxicity up to 100 µM; its isomer ursolic acid (UA) had an IC₅₀ of 47.5 µM (MTT). OA is the gentler triterpene choice.

Cosmetic value Supports the cell’s endogenous defense against environmental stress · Helps maintain a more stable skin state

Data sources: Wójciak-Kosior M et al. Folia Histochem Cytobiol. 2011;49(4):664-669. DOI:10.5603/FHC.2011.0050; Wang W et al. Curr Top Med Chem. 2022;22(1).

11 · EPIDERMAL HOMEOSTASIS

Epidermal Homeostasis: Experimental Evidence for Barrier Resilience

Mechanistic Landing Point: PPAR-α and Epidermal Differentiation Markers

In HaCaT keratinocytes, oleanolic acid (10 µmol/L, 24 h) raised PPAR-α, involucrin, loricrin, and filaggrin protein expression to about 2× control; electron microscopy showed increased lamellar body secretion and more complete lipid bilayer formation.

Cosmetic value Supports epidermal homeostasis and barrier resilience · Helps maintain healthy skin barrier function · Completes the oily-skin care logic together with oil control and soothing

Data source: Lim SW et al. J Dermatol. 2007;34(8):625-634. DOI:10.1111/j.1346-8138.2007.00344.x (animal and cell evidence).

12 · MATRIX PROTECTION

Guarding the ECM: From Oxidative Stress to Collagen Degradation

▲ Oleanolic acid’s known evidence sits at upstream nodes: modulating oxidative stress and inflammatory signaling (NF-κB / MAPK family), influencing the matrix degradation cascade from its source.

ECM-Related Evidence Leads

■ Delivery + collagen patent An oleanolic acid liposome composition patent (CN 103221028 B) targets collagen production, showing that “delivery technology + ECM” is an industry-recognized R&D path■ Photoaging use patent A composition patent for pentacyclic triterpenic acids in preventing photoaging and sensitive skin (US 2001/0029266 A1)■ Mechanistic level MAPK / NF-κB modulation evidence (see the inflammation chapter) covers upstream MMP signaling

Evidence Boundary Statement

Current ECM-related evidence for oleanolic acid consists mainly of patents and mechanistic studies; human anti-wrinkle clinical data are still lacking. This material therefore avoids statements like “reduces wrinkles by XX%” and instead positions oleanolic acid as an upstream modulator of the oxidative stress – inflammation – matrix degradation cascade.

Cosmetic value Supports ECM homeostasis · Helps reduce stress-induced matrix degradation · Maintains a collagen-rich skin structure · Supports skin elasticity and firmness

References: CN 103221028 B; US 2001/0029266 A1; Kang YM et al. Int J Mol Sci. 2021;22:12000 (patent- and mechanism-level evidence).

PART II · SCALP SCIENCE

Skin biology doesn’t stop at the hairline.

From skin to scalp — shared sebum, inflammation, and oxidative stress biology.

The scalp is an extension of the skin: dense sebaceous glands, dense follicles, and androgen sensitivity. The mechanistic evidence for oleanolic acid in facial sebum management applies equally to the scalp scenario.

13 · SCALP & ANDROGEN BIOLOGY

Scalp Oil and Androgen Biology: Same Target, Second Scenario

Recalling the page-8 data: oleanolic acid concentration-dependently inhibits 5α-reductase in vitro (56.3% inhibition at 0.1%, US 7,182,963 B2) — a mechanism pointing to both facial sebum and scalp oil scenarios.

What Makes the Scalp Scenario Special

· High sebaceous gland density: oil oxidation products and flora metabolites together form an irritation source· Follicles are sensitive to androgen signaling; DHT-related follicular microenvironment stress is a focus of hair-care research· Scalp care is shifting from “hair-fiber cosmetic finish” to “scalp ecology management”

Compliant Cosmetic Language

· Helps maintain a healthy scalp oil environment · Supports scalp ecological balance · Helps maintain a healthy follicular microenvironment · Supports scalp and follicle vitalityNo “anti-hair-loss / hair-growth / hair-loss treatment” claims.

References: US 7,182,963 B2; WO 2017/021247 A1 (hair-care composition patent containing oleanolic acid blends).

14 · FOLLICULAR MICROENVIRONMENT

The Follicular Microenvironment: More Than Just “Oil Control”

A 6-month open human study (56 subjects with androgenetic alopecia and telogen effluvium) showed that a scalp lotion containing oleanolic acid, apigenin, biotinyl tripeptide-1, and other ingredients significantly increased total hair count and anagen hair count. Oleanolic acid plays the 5α-reductase-modulating role in the blend.

Dermatologist Assessment (D180, full sample)

35.7%hair felt denser and fuller 37.5%overall hair appearance improved 39.3%scalp coverage improved

Reading the Evidence

· Human data from a multi-ingredient blend cannot be attributed to oleanolic acid alone;· Yet it is directionally consistent with the in-vitro 5α-reductase evidence, forming a “mechanism + clinical signal” combination;· No adverse events were reported throughout, with favorable usability ratings.

Cosmetic narrative: balanced scalp oil → a healthier follicular environment → support for hair vitality. Focus on “scalp care,” not “hair-loss treatment.”

Data source: Garre A et al. J Cosmo Trichol. 2018;4(1):1000132. DOI:10.4172/2471-9323.1000132 (multi-ingredient blend, 6-month open study).

15 · WHY NANOGEL MATTERS

Why Does Nanogel Matter So Much for Oleanolic Acid?

Conventional Oleanolic Acid (Crystalline Raw Material) PuriActives® OleaXin™ (Nanogel Active System)
Poor compatibility with aqueous systems Aqueous-compatible Nanogel format
Hard to disperse; requires pre-dissolving / solubilization design Improved dispersion; more direct dosing
Crystallization / precipitation risk Nanostructured presentation lowers recrystallization tendency
Limited dosage-form and formulation freedom Greater formulation flexibility (serum / gel / emulsion / scalp essence)
A conventional active format A delivery-enabled active for modern formulations

Each comparison dimension corresponds to verifiable technical basis: oleanolic acid’s lipophilicity and solubilization difficulty are documented in literature and patents (US 2001/0029266 A1; Wang et al. 2022); Nanogel-side statements describe delivery system design characteristics, with specific parameters subject to measured values in the PuriPharm TDS.

16 · FORMULATOR VALUE

What Does It Mean for Formulators?

  • A more convenient way to use oleanolic acid No need to solve solubilization from scratch; the active is dosed directly in water-dispersible form
  • Greater formulation freedom Less reliance on high-ethanol or high-oil solubilization
  • Compatible with modern water-based serum systems Works in serums, gels, emulsions, and other mainstream formats
  • Skin Care + Scalp Care dual scenarios One active covers both facial and scalp product lines
  • Fewer complex pre-dissolving steps Shorter process chain and lower batch-to-batch content-variation risk
  • An easy nano-technology product story The Nanogel delivery narrative combines scientific credibility with market recognition
  • Supports lightweight dosage forms Matches the “fresh, non-greasy feel” brief of oily-skin care

Hard-to-Formulate Bioactive → Ready-to-Use Advanced Active

17 · APPLICATIONS — SKIN CARE

Skincare Applications: Every Direction Has a Biological Basis

Sebum balance serum 5α-reductase modulation acting on upstream sebum-signaling (in-vitro enzymatic evidence)
Blemish-care serum Multi-link support across sebum + microbial environment + inflammatory signaling (in-vitro / animal evidence)
Lightweight oil-control moisturizer Aqueous-compatible Nanogel format suits fresh, light-feel systems (delivery system design feature)
Soothing serum NF-κB / STAT1 inflammatory-signal modulation improves comfort under stress (animal + cell evidence)
Antioxidant defense serum Supports endogenous defense pathways rather than relying on direct radical scavenging (mechanism-level evidence)
Anti-aging direction serum Upstream modulation of the oxidative stress – inflammation – matrix degradation cascade (patent and mechanistic evidence)
Urban stress protection Dual oxidative + inflammatory stress management for UV / pollution scenarios (mechanism-level evidence)

Application directions are development suggestions; specific efficacy claims must be based on finished-formula efficacy evaluations; evidence levels are annotated in each row.

18 · APPLICATIONS — SCALP CARE

Scalp-Care Applications: A Scalp-First Formulation Mindset

From “smoothing the hair fiber” to managing scalp ecology — this is the upgrade direction the scalp-care category is undergoing.

Scalp balance serum Scalp sebum modulation and oil-environment management (supported by in-vitro 5α-reductase evidence)
Oil-control scalp serum A fresh, water-based-compatible formula for oily scalps
Leave-on scalp lotion A leave-on format covering follicular microenvironment management
Soothing scalp care Inflammatory-signal modulation to help relieve scalp discomfort (animal + cell evidence)
Hair vitality essence Follicular microenvironment + oxidative stress management supporting a healthy hair-growth environment (multi-ingredient clinical signal)
Anti-grease scalp care Daily management of scalp oil oxidation and the flora environment

Compliance note: scalp applications focus on “scalp care” and the “hair vitality environment”; no anti-hair-loss, hair-growth, or hair-loss-treatment claims; multi-ingredient human study data serve only as directional mechanistic reference.

19 · CONCEPT SHOWCASE

Product Concept Examples

OleaXin™ Sebum Reset Serum

Sebum regulation + inflammatory balance + oxidative defense — a daily management serum for oily skin

OleaXin™ Clear Balance Essence

Environment management for blemish-prone skin: sebum balance + microbial environment + soothing

OleaXin™ Matrix Defense Serum

Upstream defense against oxidative stress and the matrix degradation cascade — anti-aging direction

OleaXin™ Scalp Balance Serum

A scalp-balancing serum covering scalp sebum + soothing + follicular microenvironment

OleaXin™ Follicular Vitality Essence

A leave-on scalp essence for oxidative stress + follicular environment + scalp vitality

Concept Design Principles

· Each concept maps to a defined combination of biological targets, not a pile-up of claims;· Concepts are development-direction examples only and contain no experimentally unverified formula ratios;· For use levels, compatibility, and stability data, refer to the PuriPharm TDS and formulation guide;· Finished-product efficacy claims are subject to the final product’s efficacy evaluation.

20 · VALUE SUMMARY

OleaXin™ Core Value: Three Pillars

PILLAR IMultifunctional Biology PILLAR IIAdvanced Delivery PILLAR IIIFormulation Value
Sebum regulation · inflammatory balanceOxidative stress defense · ECM protectionEpidermal homeostasis · scalp homeostasisA multi-target evidence chain, from in-vitro enzymology to human study signals Phospholipid Nanogel delivery systemNanostructured presentationAqueous-system compatibilityChanging how the active exists in a formula, not the molecule itself Flexible formats · easy dosingSkin & scalp dual-scenario coverageA nano-technology product narrativeFrom hard-to-formulate bioactive to ready-to-use advanced active

Bringing the scientific potential of oleanolic acid into modern formulations.UNLOCKING THE COSMETIC POTENTIAL OF OLEANOLIC ACID

21 · SELECTED REFERENCES

Key References and Patents

Peer-Reviewed Papers

[1] Kang YM, Kim HM, Lee M, An HJ. Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro. Int J Mol Sci. 2021;22(21):12000. DOI:10.3390/ijms222112000[2] Lim SW, Hong SP, Jeong SW, et al. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via PPAR-α. J Dermatol. 2007;34(8):625-634. DOI:10.1111/j.1346-8138.2007.00344.x[3] Wójciak-Kosior M, Paduch R, Matysik-Woźniak A, et al. The effect of ursolic and oleanolic acids on human skin fibroblast cells. Folia Histochem Cytobiol. 2011;49(4):664-669. DOI:10.5603/FHC.2011.0050[4] Garre A, Piquero J, Trullas C, Martinez G. Efficacy and Safety of a New Topical Hair Loss-Lotion Containing Oleanolic Acid, Apigenin, Biotinyl Tripeptide-1, Diaminopyrimidine Oxide, Adenosine, Biotin and Ginkgo biloba. J Cosmo Trichol. 2018;4(1):1000132. DOI:10.4172/2471-9323.1000132 (multi-ingredient blend)[5] Ayeleso TB, Matumba MG, Mukwevho E. Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases. Molecules. 2017;22(11):1915. DOI:10.3390/molecules22111915[6] Wang W, Li Y, Li Y, et al. Oleanolic Acid: Structural Modification and Biological Activities. Curr Top Med Chem. 2022;22(1). DOI:10.2174/1568026621666211105101231

Patents and Technical Documentation

[7] US 7,182,963 B2. Cosmetic and dermopharmaceutical compositions for skin prone to acne (contains in-vitro 5α-reductase enzymatic data for oleanolic acid; family: US 2006/0239957 A1)[8] US 2001/0029266 A1. Composition containing a pentacyclic triterpenic acid (solubilization of pentacyclic triterpenic acids)[9] WO 2017/021247 A1. Anti-hair loss lotion (hair-care composition containing oleanolic acid blends)[10] CN 103221028 B. Oleanolic acid liposome composition (collagen direction)[11] CN 103648502 B. Anti-inflammatory use of oleanolic acid acetate[12] Attached technical documentation: 28-day human efficacy test of an oleanolic acid-containing blend (gloss / pores / sebum flow, n≈20)

Disclaimer

This material is prepared by PuriPharm Co., Ltd. for cosmetic ingredient technical exchange only and constitutes no pharmaceutical or medical claims. In-vitro / animal study data do not represent finished-product human efficacy; third-party literature and patent data are cited as technical background only. Customers should independently verify the suitability and regulatory compliance of their finished formulations. PuriActives® and OleaXin™ are trademarks of PuriPharm Co., Ltd.

PuriPharm Co., Ltd. · www.puriactives.com · service@puripharm.com

PuriActives® ChitoQ

PuriActives® ChitoQ

INCI: Chitosan Hydroxypropyltrimonium Chloride

A permanently cationic chitosan derivative that delivers conditioning, moisturization, and antimicrobial support for skin and hair through a single bio-based polymer.

For cosmetic formulators · R&D scientists · Product development and brand innovation teams

01 · FORMULATION CHALLENGE

An excellent biopolymer constrained by pH

The limitation of native chitosan

  • Its amino-group charge exists only below pKa ≈ 6.3–6.5; above that range, both charge and solubility collapse.
  • It requires acidic systems, limiting dosage-form choices and active-ingredient combinations.
  • Its performance is weakest across the true pH range of skin and hair products (4.5–7).

New market requirements

  • Bio-based, biodegradable conditioning polymers.
  • Multifunctionality in one ingredient: conditioning + moisturization + microbial support.
  • Rinse-resistant deposition without build-up or tackiness.

Sources: chitosan pKa and pH-dependent charge—J. Mater. Chem. B 2023; ACS Appl. Mater. Interfaces 2023.

02 · PRODUCT OVERVIEW

One molecule, two care categories.

PuriActives® ChitoQ is a quaternized chitosan: a marine-derived polysaccharide carrying permanent quaternary ammonium groups. It is water-compatible, permanently cationic, and multifunctional for both leave-on and rinse-off systems.

  • Cationic affinity deposition on hair keratin and skin surfaces.
  • Conditioning, cuticle smoothing, and anti-static performance.
  • Moisturization benchmarked against hyaluronic acid.
  • Broad-spectrum antimicrobial and anti-biofilm support.
  • A bio-based, biodegradable alternative to synthetic polyquaterniums.

pH 3–10Maintains permanent cationic character across the formulation pH window 0.625 mg/mLMIC against Streptococcus mutans—90% growth inhibition in vitro
98.5%Degree of substitution in the current batch (specification ≥ 80%) CosIngEU-listed INCI—functions: hair conditioning and humectant

Sources: Gao et al., Molecules 2024 (S. mutans, in vitro); EU CosIng database; Puripharm batch COA (May 2026).

03 · MOLECULAR DESIGN

From chitosan to ChitoQ: functional quaternization

Permanent cationic charge

Quaternary ammonium groups never deprotonate, preserving charge across the full cosmetic pH range.

True water compatibility

It dissolves directly in water without acidification—add it to the water phase and formulate freely.

Stronger surface affinity

Electrostatic binding to anionic keratin and skin surfaces drives affinity deposition and film formation.

The quaternization route follows the published synthesis of N-2-hydroxypropyltrimethylammonium chloride chitosan (Gao et al., Molecules 2024).

04 · PHYSICOCHEMICAL PROPERTIES

Positive charge at any formulation pH

Unconditional charge

Quaternary ammonium groups remain protonated from acidic to weakly alkaline media—affinity deposition no longer depends on pH.

Soluble where chitosan is not

High-substitution HACC forms clear aqueous solutions (transmittance >80% at 80% substitution)—no acidification or pre-dissolution required.

Built for deposition

High permanent charge density maximizes electrostatic interaction with anionic keratin and skin—the physical basis for conditioning and film formation.

Sources: ACS Appl. Mater. Interfaces 2023 (zeta potential of quaternized chitosan, pH 3–10); ACS Omega 2021 (QCS charge retention); Gao et al., Molecules 2024 (solubility).

05 · MECHANISM OF ACTION

Designed to bind precisely where damage occurs

  1. Selective attraction: the isoelectric point of hair keratin is approximately 3.67. At cosmetic pH, hair carries a net negative charge, and damaged fibres are even more negatively charged.
  2. Cationic deposition: ChitoQ adsorbs to anionic sites through electrostatic interaction, concentrating deposition where the fibre needs it most and resisting rinse-off.
  3. Conditioning film: the bound polymer forms a smooth, hydrophilic film that lays cuticles flat, reduces friction and static, and helps retain surface moisture.

The same physical mechanism works on skin: an affinity, breathable cationic film binds water and supports the surface barrier—one mechanism, two categories.

Source: hair isoelectric point and cationic deposition mechanism—Gavazzoni Dias et al., On Hair Care Physicochemistry, Int. J. Trichology / PMC9921463.

EVIDENCE SECTION

Performance evidence

Quantified results from peer-reviewed research on ChitoQ chemistry, presented with transparent evidence grading.

A | Studies on ChitoQ chemistry itself (Chitosan Hydroxypropyltrimonium Chloride)

B | Structurally similar quaternized chitosan—mechanistic support

C | General chitosan literature—physicochemical background

06 · HAIR-CARE PERFORMANCE

Affinity conditioning beyond rinse-off

A cationic film restores surface smoothness and shine.

Targeted deposition on damaged keratin [B]

The affinity of quaternized chitosan for hair keratin has been demonstrated, and its strengthening and conditioning effects have been documented since the earliest quaternized-chitosan patents.

Easier wet and dry combing [C]

The adsorbed film reduces inter-fibre friction, helps detangling, and reduces mechanical breakage during combing.

Anti-static and frizz control [C]

Charge neutralization plus a smoothing film minimizes static and seals cuticles against humidity-induced frizz.

Shine, softness, and color protection [C]

Flat cuticles reflect light evenly, while the protective film helps color resist washing and UV exposure.

Added scalp-care benefit [A]

Demonstrated antimicrobial activity extends the benefit from the hair fibre to the scalp environment.

Damaged hair has a lower isoelectric point and a denser negative surface charge, so cationic polymers deposit preferentially where repair is most needed.

Sources: US 4,772,689 (Lang et al., quaternized-chitosan affinity); PCACD 2024 review (chitosan hair care); Gao et al., Molecules 2024. See the evidence section for [A]/[B]/[C] grading.

07 · SKIN-CARE PERFORMANCE

Hyaluronic-acid-level moisturization

[A] HACC performs within the hyaluronic-acid range, and its ion-exchange derivative can reach 2.2× HA. At 43% RH, the HACC derivative also absorbed more moisture than HA (74–94% vs 32.4%, 48 h).

Dual water management

A surface rich in hydroxyl and quaternary ammonium groups binds water through hydrogen bonding, while the affinity film helps slow transepidermal water loss. [A/C]

Breathable barrier support

Chitosan films are non-occlusive: they buffer the stratum corneum against environmental stress while allowing skin to function normally. [C]

Sensory differentiation

The cationic film provides a distinctive smooth, cushioned after-feel—a humectant consumers can actually perceive. [C]

Sources: Mi et al., Polymers 2021 (PMC8307204)—in vitro comparison of moisture absorption/retention by HACC, its derivatives, and sodium hyaluronate; chitosan film/TEWL literature (PCACD 2024).

08 · ANTIMICROBIAL SUPPORT

A cationic mechanism acting on microbial surfaces

0.625 mg/mLMIC of N-2-HACC against S. mutans; 90.0% growth inhibition at the MIC [A] > 90%Inhibition of E. coli and S. aureus by quaternized chitosan salts at 0.5 mg/mL [B] BiofilmFormation is significantly inhibited, with activity increasing as substitution degree rises [A/B]

How the permanent charge works [A]

  • Electrostatic binding to negatively charged cell envelopes.
  • Increased cell-wall permeability (alkaline phosphatase leakage).
  • Disrupted membrane integrity—visible pitting under SEM.
  • Inhibited respiratory metabolism and protein/DNA synthesis.

Gentle, film-forming antimicrobial support for leave-on systems. Position it as preservative-boosting support; actual in-formula performance must be confirmed by preservative challenge testing.

Sources: [A] Gao et al., Molecules 2024 (N-2-HACC against S. mutans; MIC/SEM/biofilm); [B] Wang et al., Int. J. Biol. Macromol. 2024 (chitosan quaternary ammonium salts; E. coli/S. aureus).

09 · SAFETY AND MILDNESS

Cationic performance without the baggage

ChitoQ carries its charge on a high-molecular-weight polysaccharide backbone—it stays on the surface where it works, rather than penetrating like a small-molecule quaternary ammonium salt.

No cytotoxicity in cell testing [A]

HACC-based derivatives showed no significant toxicity toward L929 fibroblasts; independent literature describes N-2-HACC as having very low toxicity and high safety.

Bio-based and biodegradable [A/C]

The marine-derived polysaccharide backbone addresses sustainability and environmental-persistence concerns associated with traditional synthetic cationic polymers.

Built-in antioxidant benefit [A]

Beyond conditioning, HACC derivatives show free-radical scavenging activity (DPPH and superoxide anion).

A high-molecular-weight cationic biopolymer designed for surface action. Finished-formula suitability and regulatory compliance remain the responsibility of the product developer; a complete toxicology dossier is available upon request.

Sources: Han et al., Int. J. Biol. Macromol. 2024 (L929 cytotoxicity and antioxidant assays); Gao et al., Molecules 2024; Processes 2026 review (limitations of cationic systems).

10 · HAIR + SCALP SYNERGY

One functional biopolymer—two cosmetic interfaces

Hair fibre

  • Targeted deposition [B]: cationic chains anchor to negatively charged damaged keratin sites.
  • Cuticle smoothing [C]: the adsorbed film lays raised cuticles flat and reduces inter-fibre friction.
  • Anti-static control [C]: charge neutralization tames static and humidity-induced frizz.
  • Protective conditioning layer [B]: the affinity polymer film helps protect hair from daily mechanical damage.

Scalp

  • Moisture management [B]: the humectant polysaccharide film helps retain water at the scalp surface.
  • Surface comfort film [C]: an ultra-thin polymer layer provides a smooth, protected skin feel.
  • Microenvironment support [A]: demonstrated antimicrobial activity supports scalp-care concepts.
  • Formulation support [A]: water-phase compatibility simplifies scalp lotions, essences, and cleansing formulas.

The charge-affinity mechanism that conditions hair also serves the skin where hair grows.

See the evidence section for grading. Sources: Gao et al., Molecules 2024 [A]; Mi et al., Polymers 2021 [B]; US 4,772,689 [B].

11 · PERFORMANCE ARCHITECTURE

One polymer, six cosmetic functions.

01 CONDITION | Affinity cationic deposition

Permanent charge anchors the polymer to hair keratin and skin surfaces for rinse-resistant conditioning. [B]

02 SMOOTH | Film-forming surface refinement

An ultra-thin adsorbed film smooths cuticles and skin microrelief, reducing friction and roughness. [C]

03 HYDRATE | Water retention and binding

The hydrophilic polysaccharide structure binds water, with moisturization benchmarked against hyaluronic acid. [B]

04 PROTECT | Polymer protective interface

The deposited layer buffers hair fibres and skin surfaces against mechanical and environmental stress. [C]

05 CONTROL | Anti-static and manageability

Charge neutralization reduces static and makes wet and dry combing easier. [C]

06 SUPPORT | Skin and scalp-care functions

Demonstrated antimicrobial and moisturizing activity extends care from hair fibres to scalp and skin. [A]

Molecule → mechanism → performance → formulation → consumer benefit

The functional portfolio is limited to scientifically supported roles; see the evidence section for grading.

12 · APPLICATION OPPORTUNITIES

One ingredient, two care categories

Hair and scalp

  • Conditioning shampoos—deposition without build-up; compatible with amphoteric surfactant systems.
  • Rinse-off conditioners and masks—wet-combing slip, cuticle sealing, and shine.
  • Leave-on anti-frizz serums/sprays—an anti-static film with humidity resistance.
  • Scalp lotions—moisturization plus microbial-balance support.
  • Color-care systems—film protection against wash-out and UV fading.

Face and body

  • Moisturizing serums/essences—hyaluronic-acid-level hydration with a perceptibly cushioned skin feel.
  • Moisturizers and barrier creams—a breathable film that slows water loss.
  • Sheet-mask essences—affinity hydration that lasts after mask removal.
  • Facial mists/toners—water-clear and non-tacky.
  • Gentle cleansers—a conditioned after-feel with a microbial-support story.

Every concept inherits the same trio: affinity deposition · moisturization · microbial support

Concept directions are provided for development reference only; prototype formulas are available from the Puripharm application laboratory.

13 · FORMULATION GUIDE

Born for the water phase

Parameter Guidance
INCI / form Chitosan Hydroxypropyltrimonium Chloride—off-white powder
Use level Varies by dosage form—the Puripharm application laboratory provides system-specific starting recommendations
Solubility Readily soluble in water across a broad pH window—no acidification required
Working pH Functional pH 3–10; comfortable formulation range pH 4–8
Addition Disperse in the water phase under moderate stirring until clear
Compatibility Cationic—avoid strongly anionic surfactants/polymers; best paired with nonionic and amphoteric systems
Process tolerance The polysaccharide backbone is stable; add below 80 °C to protect color and viscosity

Formulator notes

  • Rinse-off products: deposit first, rinse second—affinity withstands dilution.
  • Screen salts—high ionic strength compresses charge interactions.
  • Brings light, elegant viscosity to aqueous systems.
  • Pair with humectants (glycerin, betaine, PCA) to strengthen the hydration story.
  • Confirm preservative synergy in the final base through challenge testing.

Prototype formulas (conditioning shampoo, moisturizing serum, and scalp lotion) are available from the Puripharm application laboratory.

Guidance is based on published physicochemical behavior of quaternized chitosan and Puripharm application experience; validate in the final formula.

14 · DIFFERENTIATION

A bio-based answer to synthetic cationic polymers

Dimension PURIACTIVES® CHITOQ Native chitosan Synthetic polyquaterniums
Source Marine-derived, bio-based Marine-derived, bio-based Petrochemical
Charge vs pH Permanently cationic, pH 3–10 Only below pKa ≈ 6.5 Permanently cationic
Water compatibility Direct dissolution, no acidification Acidic media only Good
Affinity High—keratin and skin Moderate, pH-limited High
Multifunctionality Conditioning + moisturization + antimicrobial support Film-forming and moisturizing Conditioning only
End of life Biodegradable polysaccharide Biodegradable Persistence concern

Synthetic-grade performance with a biopolymer story—without naming any commercial competitor.

15 · QUALITY AND REGULATORY

Batch traceability—all 11 tests passed

Specification vs representative production batch

Test item Specification Batch result
Appearance Off-white powder Complies
Solubility Soluble in deionized water Complies
Moisture ≤ 10.0% 8.7%
Ash ≤ 1.0% 0.45%
pH (1% solution) 5.5–7.5 6.41
Viscosity (1% aqueous solution, 20 °C) Meets product claim 18 mPa·s
Degree of deacetylation ≥ 85.0% 89.2%
Degree of substitution ≥ 80.0% 98.5%
Arsenic (As) ≤ 4.0 mg/kg Not detected (< 0.01)
Lead (Pb) ≤ 2.0 mg/kg Not detected (< 0.02)
Water-insoluble matter ≤ 0.5% 0.03%
11 / 11All quality tests passed for the current production batch 98.5%Degree of substitution; specification ≥ 80% NDArsenic and lead below detection limits (< 0.01 / < 0.02 mg/kg)

Regulatory identity

The INCI name Chitosan Hydroxypropyltrimonium Chloride is listed in the EU CosIng database with hair-conditioning and humectant functions. Each batch is supplied with COA, TDS, and SDS.

Puripharm Co., Ltd. batch inspection report (May 2026); complete COA, TDS, and SDS are available upon request. EU CosIng listed functions: hair conditioning and humectant.

16 · SUMMARY

ChitoQ earns a place in your formula

Marine chitosan backbone → functional quaternization → water compatibility + permanent charge → biological surface binding → multifunctional performance

No more formulation compromise

Water compatibility across pH 3–10 ends the acidic-system constraint of native chitosan.

Performance that stays

Permanent cationic affinity delivers rinse-resistant conditioning and moisturization.

A cleaner label story

Bio-based, biodegradable, and clean in cell testing—a credible successor to synthetic polyquaterniums.

Honestly graded evidence

ChitoQ-specific data lead the story; related quaternized-chitosan and chitosan literature is clearly labeled.

One SKU, three functions

Conditioning, moisturization, and antimicrobial support simplify formulas and strengthen claims.

End-to-end support

Specifications, dossiers, and prototype formulas travel with the ingredient—not as an afterthought.

ChitoQ turns an exceptional biopolymer into a reliable formulation tool.

PURIPHARM CO., LTD.

Let’s build the next generation of care products together.

Request PuriActives® ChitoQ samples, specifications, safety dossiers, and prototype formulas.

Website www.puriactives.com
Email service@puripharm.com
Phone +86-572-2745768
Address Building 6, No. 1366 Hongfeng Road, Huzhou, Zhejiang, China

PuriActives® and ChitoQ® are registered trademarks of Puripharm Co., Ltd. This presentation introduces a cosmetic ingredient only and contains no drug claims. In vitro and third-party literature data are identified and do not represent clinical performance of finished products.

NanoActive™Retinal – Bakuchiol 纳米包裹视黄醛-补骨脂酚

NanoActive™Retinal – Bakuchiol

Nano-Encapsulated Retinal–Bakuchiol

Dual-Pathway Retinoid Renewal · Nano-Delivery Technology

INCI NAME — RETINAL, BAKUCHIOL

PuriPharm Co. Ltd. · Technical Marketing Presentation

02 · RETINOID CARE — THE NEXT CHAPTER

Retinoid Care Is Entering Its Next Stage

Retinoids remain the most evidence-supported active family for managing skin photoaging. The questions facing brands and formulators have moved beyond whether a formula contains a retinoid to four more fundamental issues: Can the active be converted efficiently? Can it remain stable? Can consumers sustain long-term use? Does the formula provide sufficient design freedom?

Core question Explanation
01 Efficacy Retinoids must be converted to retinoic acid to act; the conversion pathway determines the speed and intensity of activity.
02 Stability High activity comes with sensitivity to light and oxygen; active retention during shelf life and in-formula is essential.
03 Tolerance Irritation determines adherence, and adherence determines whether long-term benefits can be realized.
04 Formulation Dosage form, sensory profile and system compatibility define the space for product differentiation.

The next-stage answer: advanced actives × complementary mechanisms × nano delivery.

03 · PRODUCT OVERVIEW

NanoActive™ Retinal-Bakuchiol

Identity Information
Product name Nano-Encapsulated Retinal–Bakuchiol
INCI name Retinal, Bakuchiol
Technology platform NanoActive™ nano-encapsulation and delivery system
Application settings Dual use across skin care and scalp care
01 Biology: Retinal is the direct precursor of retinoic acid; one oxidation step drives advanced retinoid biology.
02 Synergy: Bakuchiol supports retinol-like gene expression, antioxidant defense, inflammatory modulation, extracellular-matrix biology and skin homeostasis.
03 Delivery: NanoActive™ improves protection, dispersion, formulation suitability and delivery performance for sensitive actives.

This is not a simple ingredient blend. It is a next-generation dual-pathway renewal platform integrating high-efficiency renewal, complementary mechanisms, nano delivery and both skin and scalp applications.

04 · 01 · BIOLOGY — RETINAL

Why Retinal: Closer to the Active EndpointRetinyl esters → Retinol → Retinal → Retinoic acid

Metabolic node Description
Retinyl esters Storage form; hydrolyzed to retinol.
Retinol Requires a rate-limiting oxidation step to form retinal.
Retinal An advanced cosmetic retinoid that requires only one oxidation step to form retinoic acid.
Retinoic acid The active retinoid endpoint; a drug active not permitted as a cosmetic ingredient.
Key advantage Data and significance
Approximately 3× biological activity Bypassing retinol’s first rate-limiting oxidation step gives retinal approximately three times the retinoid biological activity of retinol.
At least 11× faster conversion Conversion of retinal to retinoic acid is estimated to be more than 11 times faster than the retinol pathway and occurs in both differentiated and undifferentiated keratinocytes.

Retinal is the direct precursor of retinoic acid—an advanced retinoid positioned closer to the active endpoint.

Siegenthaler G, Saurat JH, Ponec M. Biochem J. 1990;268(2):371–378. | Brown A, et al. Dermatol Ther (Heidelb). 2023;13(10):2299–2317.

05 · 01 · BIOLOGY — ADVANCED RETINOID BIOLOGY

One Oxidation Step Directly Drives Classical Retinoid SignalingRetinal → one-step oxidation → retinoic acid → RAR/RXR nuclear receptors → target-gene transcription → visible epidermal and dermal renewal

01 Retinal undergoes one oxidation step inside keratinocytes to form retinoic acid.
02 Retinoic acid binds nuclear RAR receptors and forms heterodimers with RXR.
03 RAR-RXR binds promoter regions and regulates target genes involved in skin biology.
04 The result is visible renewal across both the epidermis and dermis.
Level Biological effects
Epidermis Accelerated epidermal renewal; regulation of keratinocyte differentiation; increased epidermal thickness; upregulation of RA-activity markers such as CRABP-II; regulation of barrier- and hydration-related genes; improved desquamation, texture refinement and tone uniformity.
Dermis Support for fibroblast function and extracellular-matrix remodeling; new collagen deposition; inhibition of UV-induced MMP-related matrix degradation; restoration of the elastic-fiber network; visible outcomes in wrinkles, texture, laxity and photoaging pigmentation.

A complete retinoid-biology pathway drives systematic renewal from the epidermis to the dermis.

Saurat JH, et al. J Invest Dermatol. 1994;103(6):770–774. | Fisher GJ, et al. Nature. 1996;379(6563):335–339. | Xiao JH, et al. J Biol Chem. 1995;270(7):3001–3010.

06 · 01 · BIOLOGY — EPIDERMIS TO DERMIS

Retinal: From Epidermal Renewal to Dermal RemodelingEpidermis: renewal, differentiation, thickness and texture; Dermis: fibroblasts, collagen, elastic fibers, ECM and MMP management

Evidence Finding
Human study: epidermis and elasticity After one year of 0.05% retinaldehyde, high-resolution ultrasound and rheological measurements showed significant increases in epidermal thickness and skin elasticity (p < 0.01), with a trend toward increased dermal thickness.
Ex vivo: repair of UVA damage In a UVA-photodamaged human skin model, two weeks of 0.05% retinaldehyde restored elastic fibers and collagen to levels close to non-photodamaged skin.
Biological effects in human skin Topical retinaldehyde induced typical retinoid effects, including epidermal thickening and CRABP-II expression, while maintaining good tolerance.

Metabolic position → retinoid biology → epidermal renewal → ECM/collagen/elastin support → visible human outcomes: one complete evidence chain.

Diridollou S, et al. Dermatology. 1999;199(Suppl 1):37–41. | Boisnic S, et al. Dermatology. 1999;199(Suppl 1):43–48. | Saurat JH, et al. J Invest Dermatol. 1994;103(6):770–774.

07 · 01 · CLINICAL EVIDENCE — PHOTOAGING

Human Photoaging: Improvement Comparable to Retinoic Acid

Study design Details
Randomized controlled study n=125; 18 weeks; optical profilometry; 0.05% retinaldehyde (n=40) versus 0.05% retinoic acid (n=40) versus vehicle (n=45).
Dimension Result
Efficacy: comparable Both actives significantly reduced wrinkles and skin roughness; no statistically significant efficacy difference was observed between retinaldehyde and retinoic acid. An open study (n=32, four months) also found clear reductions in surface roughness and coarse wrinkles.
Tolerance: better Local irritation was more frequent with retinoic acid and affected adherence. Retinaldehyde caused fewer local adverse reactions and supported better long-term adherence. Comparable efficacy plus better tolerance forms retinal’s core value proposition.

In photoaged human skin, 0.05% retinaldehyde delivered wrinkle and roughness improvements comparable to 0.05% retinoic acid while maintaining significantly better local tolerance.

Creidi P, et al. J Am Acad Dermatol. 1998;39(6):960–965. | Creidi P, Humbert P. Dermatology. 1999;199(Suppl 1):49–52. | Mukherjee S, et al. Clin Interv Aging. 2006;1(4):327–348.

08 · 01 · CLINICAL EVIDENCE — LONG-TERM

Elasticity, Skin Thickness and Long-Term Performance

One-Year Instrumental Study: 0.05% Retinaldehyde

n=21 in the retinaldehyde group versus n=19 in the emollient-control group; high-resolution ultrasound plus echorheometry; measurements at baseline and one year.

01 Temporal epidermal thickness increased significantly versus control (p < 0.01).
02 Skin elasticity improved significantly versus control using suction rheology (p < 0.01).
03 Dermal thickness showed an increasing trend, while skin stiffness showed a decreasing trend.
04 Tolerance remained good throughout, supporting long-term daily use.

Increase in Dermal Thickness with a Non-Ablative Laser Regimen

Randomized double-blind study (n=16); 0.05% retinaldehyde versus vehicle for three months.

Diridollou S, et al. Dermatology. 1999;199(Suppl 1):37–41. | Mordon data cited in Mukherjee S, et al. Clin Interv Aging. 2006;1(4):327–348.

09 · 01 · TOLERANCE PROFILE

High Activity Does Not Have to Mean High Irritation

In long-term clinical use, all three reaction rates were significantly lower with retinaldehyde; between-group analysis p < 0.0001.

Setting Finding
Maximized conditions Retinol and retinaldehyde showed similarly low irritation potential, while retinoic acid was significantly more irritating (p < 0.05). Laser Doppler confirmed an irritant effect for RA but not for ROL/RAL (p = 0.001).
Long-term clinical conditions Retinaldehyde demonstrated clear retinoid biological activity, while rates of erythema, scaling and burning/pruritus were significantly lower than with retinoic acid.
Product implication Efficacy and user experience can coexist, supporting sustained use and repurchase in premium retinoid products.

Fluhr JW, et al. Dermatology. 1999;199(Suppl 1):57–60. | Sachsenberg-Studer EM. Dermatology. 1999;199(Suppl 1):61–63.

10 · 02 · SYNERGY — BAKUCHIOL

Why Bakuchiol

Bakuchiol is a plant-derived molecule with retinol-like gene-expression effects and multi-pathway skin activity. It is more than a natural retinol alternative; it represents an independent multi-pathway biology.

Feature Description
Source and class Derived from the seeds and leaves of Psoralea corylifolia; a meroterpene phenol.
Structure and function Chemically dissimilar to retinoids but functionally analogous to retinol.
Mechanism Does not directly engage the RAR receptor pathway, helping explain its gentler tolerance profile.
Use pattern No reported photosensitivity; suitable for morning and evening use.

Retinol-like gene expression, collagen and ECM support, antioxidant defense, inflammatory-signal modulation, skin homeostasis and barrier support, and pigment management

Antioxidant defense × inflammatory modulation × ECM support × homeostasis maintenance form a second renewal pathway beyond retinal.

Chaudhuri RK, Bojanowski K. Int J Cosmet Sci. 2014;36(3):221–230.

11 · 02 · SYNERGY — GENE EXPRESSION & COLLAGEN

Bakuchiol: Retinol-Like Gene Expression × ECM Support

Evidence dimension Finding
Collagen expression Human dermal fibroblast model; ELISA; untreated control set at 100%; 10 μg/mL. Bakuchiol exceeded retinol for Collagen I and IV expression and was comparable for Collagen III.
Gene-expression profile DNA microarray analysis in a full-thickness reconstructed skin model showed highly similar overall regulation by bakuchiol and retinol, including upregulation of COL1A2, COL4A6, COL9A2, COL17A1, HAS3 and hydration-related AQP3.
Non-classical RA pathway No effect on RA receptor genes such as RARB and RARG, suggesting action through non-classical retinoic-acid signaling and supporting a gentler irritation profile.
12-week human study 0.5% bakuchiol significantly improved fine lines and wrinkles, pigmentation, elasticity, firmness and overall photodamage without the adverse effects commonly associated with retinol therapy.

Chaudhuri RK, Bojanowski K. Int J Cosmet Sci. 2014;36(3):221–230. | Brown A, et al. Dermatol Ther (Heidelb). 2023;13(10):2299–2317.

12 · 02 · BAKUCHIOL — HUMAN EVIDENCE

Comparable Efficacy to 0.5% Retinol with Better Tolerance

Study design: prospective, randomized, double-blind study; n=44; 12 weeks; 0.5% bakuchiol twice daily versus 0.5% retinol once daily; high-resolution facial imaging plus blinded dermatologist grading.

Tolerance difference Description
Retinol More facial scaling and stinging were reported.
Bakuchiol Suitable for morning and evening use, with no reported photosensitivity; offers wider design space for sensitive skin and higher-frequency use.

Head-to-head human evidence shows that bakuchiol was comparable to 0.5% retinol for both wrinkles and pigmentation, with better tolerance.

Dhaliwal S, et al. Br J Dermatol. 2019;180(2):289–296. | Draelos ZD, et al. J Drugs Dermatol. 2020;19(12):1181–1183.

13 · 03 · COMPLEMENTARY BIOLOGY

Two Actives, Two Complementary Biological Systems

Dimension Retinal Bakuchiol Complementary value
Core pathway Direct precursor of retinoic acid → classical RAR retinoid signaling Retinol-like transcriptional response via a non-classical RA pathway Dual-pathway coverage without full overlap
Epidermal action Epidermal renewal, keratinocyte differentiation and epidermal thickness Barrier and homeostasis support; enhancement of differentiation-related genes Renewal plus homeostasis
ECM/collagen Fibroblast function, new collagen deposition and MMP inhibition Collagen I/III/IV expression and ECM support Synthesis promotion × degradation management
Oxidation/inflammation Management of photoaging-related matrix degradation ROS defense and inflammatory-signal modulation A protective environment for high-efficiency activity
Pigment/blemish-prone skin Depigmenting activity, keratinization renewal and C. acnes inhibition Pigmentation improvement and blemish-prone skin support Multi-target clarity and tone management
Tolerance Significantly better than retinoic acid Better than 0.5% retinol in a head-to-head study Long-term-use friendliness for premium products

One pathway is a high-efficiency engine operating through classical RAR signaling; the other is a multi-pathway support system for homeostasis—Retinal × Bakuchiol complementary biology.

14 · 03 · DUAL-PATHWAY RENEWAL

Dual-Pathway Renewal: A More Complete Renewal LogicClassical RAR signaling from retinal plus multi-pathway homeostasis support from bakuchiol

Retinal pathway Bakuchiol pathway
One-step oxidation to retinoic acid Plant-derived meroterpene phenol
RAR-RXR heterodimer and target-gene transcription Retinol-like transcriptional response plus antioxidant and inflammatory modulation; non-classical RA pathway, NF-κB and ROS defense
Epidermal renewal, keratinocyte differentiation, ECM remodeling, collagen homeostasis and MMP management Skin homeostasis, barrier support, ECM support, photoaging defense and pigment management

Dual-pathway retinoid renewal: epidermal renewal · ECM support · oxidative defense · homeostasis maintenance.

15 · 03 · RETINAL + BAKUCHIOL — COMBINED HUMAN EVIDENCE

Combined-System Human Study: Multidimensional Signals in 28 Days

Study design: open-label proof of concept; n=32 women, 65.6% with sensitive skin; once nightly for 28 days; a complex containing 0.1% liposomal retinal plus bakuchiol, with Vigna aconitifolia extract, niacinamide and melatonin.

01 100% of subjects showed a reduction in crow’s-feet count; all 32 of 32 participants improved.
02 Good tolerance: no significant changes in erythema or burning/stinging; no participant, including those with sensitive skin, needed to alter the once-daily regimen.
03 Methods: Cutometer® for firmness R0 and elasticity R2, Primos®-CR for wrinkles and VISIA®-CR for tone; D0–D28 change from baseline; *p<0.05, ***p<0.001.

Note: These data describe the complete active system containing retinal plus bakuchiol and do not isolate the individual contribution of either ingredient.

Brown A, et al. Dermatol Ther (Heidelb). 2023;13(10):2299–2317.

16 · 03 · FROM EFFICACY TO MECHANISM

From Human Efficacy to Molecular Mechanism

01 Enhanced gene expression: In a full-thickness reconstructed human skin model, adding bakuchiol to 0.1% retinal further enhanced retinal’s regulation of keratinocyte-differentiation genes CASP14, KRT14 and TP63 and barrier genes FLG, CDSN and CLDN1. Several changes exceeded the 0.05% retinoic-acid control.
02 No increase in irritation potential: In a reconstructed human epidermis model, ET50 remained >24 hours for both 0.1% retinal alone and retinal + bakuchiol + Vigna aconitifolia extract, maintaining gentleness while improving performance.
03 Mechanistic interpretation: Bakuchiol upregulated CRABP-II and genes related to retinol metabolism, supporting efficient RA signaling and providing a complementary mechanistic explanation for combined-system efficacy.

Ex Vivo UV-Photodamaged Skin Model: Combined System

Marker Change
CRABP-II expression +68%
Hyaluronic acid +71% versus UV-exposed skin
Procollagen I +33%
Degraded collagen −46% by CHP staining
MMP-1 expression −36%
Total collagen +16%, fully preventing UV-induced loss

Scientific boundary: the evidence demonstrates multidimensional efficacy and complementary mechanisms for the combined system; it does not prove strict pharmacological synergy between the two ingredients.

Brown A, et al. Dermatol Ther (Heidelb). 2023;13(10):2299–2317.

17 · 04 · DELIVERY — THE FORMULATION CHALLENGE

Why Nano Delivery Is Needed

Retinal: high activity, high sensitivity Bakuchiol: the dispersion challenge of a lipophilic molecule
Oxidation-sensitive aldehyde structure Lipophilic and naturally incompatible with high-water systems
Light-sensitive, with activity loss under illumination Application and dispersion challenges in high-water systems
Storage-stability challenges Formula uniformity requires technical support
Free active is vulnerable to the formulation environment System compatibility requires optimization

High activity does not automatically equal high performance. An active must be protected, dispersed and delivered before efficacy can be realized in a formula. NanoActive™ encapsulation is designed for sensitive actives.

18 · 04 · DELIVERY — NANOACTIVE™ TECHNOLOGY

Nano-Encapsulation Converts High Activity into High PerformanceNano-carriers encapsulate retinal and bakuchiol across protection, dispersion, delivery and formulation performance

01 Protection: Isolates and protects sensitive actives, reducing direct exposure to light, oxygen and the formulation environment.
02 Dispersion: Improves the dispersion and uniformity of lipophilic actives in high-water systems and optimizes compatibility.
03 Delivery: Supports even delivery and distribution of actives on the skin.
04 Performance: Improves development flexibility across serums, emulsions, gels and other modern formats—converting high activity into high formulation performance.

19 · 04 · FREE ACTIVE vs NANO-ENCAPSULATED

Free Active vs Nano-Encapsulated

Free active NanoActive™ encapsulation system
Light/oxygen/formulation environment: direct exposure to degradation factors Active encapsulation: retinal and bakuchiol loaded into nano-carriers
Activity loss during storage and shelf life Protection from light, oxygen and the formulation environment
Dispersion challenge and limited uniformity in high-water systems Stable and uniform distribution in high-water systems
Restricted delivery, reduced performance and narrower dosage-form choice Uniform delivery and greater design freedom across serums, emulsions, gels and other modern formats

Specific technical parameters such as particle size, encapsulation efficiency, release profile and stability are subject to the PuriPharm product technical documents (TDS/COA).

20 · 05 · APPLICATION — SKIN PERFORMANCE

Wrinkles · Firmness · Elasticity · Renewal

01 Wrinkles and photoaging: RAR-driven epidermal renewal and dermal remodeling; a retinal + bakuchiol system reduced wrinkle count by 43.2% in 28 days (p<0.001); retinaldehyde produced wrinkle and roughness improvement comparable to retinoic acid in an n=125 randomized trial.
02 Firmness and elasticity: Support for Collagen I/III, elastin, ECM and MMP management; after 28 days, elasticity increased 13.9% (p<0.001) and firmness increased 5.6% (p<0.05); one year of 0.05% retinaldehyde significantly improved skin elasticity (p<0.01).
03 Epidermal renewal: Regulation of keratinocyte differentiation and renewal, increased epidermal thickness (p<0.01), and improved texture and radiance—the mechanistic basis for night renewal and Skin Longevity products.
04 Tone improvement: Retinal depigmenting activity and epidermal renewal plus bakuchiol-associated pigment improvement in 59% of subjects; tone uniformity increased 7.0% after 28 days (p<0.05).

Brown A, et al. Dermatol Ther (Heidelb). 2023;13(10):2299–2317. | Diridollou S, et al. Dermatology. 1999;199(Suppl 1):37–41. | Sorg O, et al. Dermatology. 2013;227(3):231–237. | Dhaliwal S, et al. Br J Dermatol. 2019;180(2):289–296.

21 · 05 · APPLICATION — ANTIOXIDANT · BLEMISH-PRONE SKIN

Antioxidant Defense and Blemish-Prone Skin Microenvironment ManagementUV/pollution → ROS → oxidative stress → inflammatory signaling → increased MMP → collagen degradation; bakuchiol supports ROS defense, inflammatory modulation and MMP management

A Distinct Antibacterial Dimension of Retinal

01 In vivo: daily 0.05% retinaldehyde reduced median viable C. acnes density by 10² log/cm² after two weeks; vehicle had no effect.
02 Comedolytic and keratinization-renewal activity was observed in an animal model.
03 Bakuchiol antioxidant and inflammatory-modulating activity supports blemish-prone skin care.
04 Cosmetic language: clarity, balance, keratin renewal, blemish-prone skin care and microenvironment management.

Pechère M, et al. Dermatology. 1999;199(Suppl 1):29–31. | Fort-Lacoste L, et al. Dermatology. 1999;199(Suppl 1):33–35. | Chaudhuri RK, Bojanowski K. Int J Cosmet Sci. 2014;36(3):221–230.

22 · 06 · SKIN & SCALP LONGEVITY

From Skin Longevity to Scalp Longevity

The scalp is an extension of facial skin. The same biology that drives facial renewal—epidermal turnover, barrier homeostasis, oxidative-stress management and ECM support—also applies to the scalp and follicular microenvironment.

Skin Longevity → Scalp Longevity → Follicular Microenvironment

Setting Core biology
Facial skin Renewal, ECM, tone and homeostasis
Scalp Keratinization renewal, barrier, ROS and inflammatory microenvironment
Follicular microenvironment Epithelial homeostasis and perifollicular ECM
01 Scalp aging involves declining barrier function, accumulated oxidative stress and changes in the follicular microenvironment, sharing a mechanistic framework with facial photoaging.
02 The dual-pathway logic of retinoid biology and antioxidant support naturally extends to scalp-renewal applications.
03 The NanoActive™ delivery system supports dispersion and delivery in lightweight scalp-serum formats.

Positioning: Scalp Longevity Active System | Scalp Longevity Serum | Advanced Scalp Renewal | Skin & Scalp Longevity

23 · 06 · SCALP & FOLLICLE BIOLOGY

Scalp Renewal and Follicular Microenvironment SupportScalp epidermis, dermal/follicular zone and follicular microenvironment

Level Support direction
Scalp epidermis Keratinization renewal, scalp barrier and homeostasis
Dermal/follicular zone Follicular epithelium, perifollicular ECM and sebaceous glands
Follicular microenvironment ROS management, inflammatory signaling and environmental stress
01 Retinoid biology and the follicle: Retinoic-acid synthesis is localized to specific regions of the follicle and sebaceous gland, including the stem-cell microenvironment. Precisely regulated RA levels are essential to follicular epithelial homeostasis.
02 Oxidative stress and scalp aging: Oxidative stress is an important driver of scalp and hair aging. Bakuchiol’s antioxidant and inflammatory-modulating properties provide protective support for the perifollicular microenvironment.
03 Product positioning: Focuses on the scalp-care environment and biological support—scalp renewal, barrier maintenance and follicular microenvironment management—without drug-like hair-growth or anti-hair-loss claims.

Everts HB. Biochim Biophys Acta. 2012;1821(1):222–229. | Trüeb RM. Int J Trichology. 2009;1(1):6–14. | Trüeb RM. Int J Cosmet Sci. 2015;37(Suppl 2):25–30.

24 · 07 · APPLICATION MAP

Multi-Setting Applications

Face Eye Scalp & Hair
Advanced anti-aging serumsNight-renewal serumsLine-smoothing serumsFirming creamsSkin Longevity productsPhotoaging careTone-radiance careBlemish-prone skin care Eye serumsLine-smoothing eye creamsCrow’s-feet managementIn the combined-system study, 100% of subjects showed fewer crow’s feet after 28 days Scalp serumsAnti-aging scalp serumsScalp Longevity SerumHair Vitality SerumNight scalp careFollicular microenvironment care

Premium concepts: Retinoid Cycling | Skin Longevity | Scalp Longevity | Healthy Aging | Preventive Aging | Night Renewal

25 · THE PLATFORM

A Next-Generation Dual-Pathway Retinoid Renewal PlatformAdvanced retinal biology + complementary multi-pathway bakuchiol activity + NanoActive™ nano delivery

Platform value Description
Performance One oxidation step to RAR signaling, supported by a complete human-efficacy evidence chain.
Complementary biology Retinol-like gene expression × antioxidant defense × homeostasis support.
Delivery Protection, dispersion and delivery convert high activity into high formulation performance.
Skin + scalp applications A platform spanning both Skin Longevity and Scalp Longevity.

NanoActive™ Retinal-Bakuchiol: Retinoid performance, redefined.

PuriActives® and NanoActive™ are trademarks of PuriPharm Co., Ltd. This material is intended solely for technical communication concerning cosmetic ingredients.

26 · SCIENTIFIC REFERENCES

Scientific References

01 Siegenthaler G, Saurat JH, Ponec M. Retinol and retinal metabolism. Relationship to the state of differentiation of cultured human keratinocytes. Biochem J. 1990;268(2):371–378.
02 Saurat JH, et al. Topical retinaldehyde on human skin: biologic effects and tolerance. J Invest Dermatol. 1994;103(6):770–774.
03 Creidi P, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol. 1998;39(6):960–965.
04 Creidi P, Humbert P. Clinical use of topical retinaldehyde on photoaged skin. Dermatology. 1999;199(Suppl 1):49–52.
05 Diridollou S, et al. Efficacy of topical 0.05% retinaldehyde in skin aging by ultrasound and rheological techniques. Dermatology. 1999;199(Suppl 1):37–41.
06 Boisnic S, et al. Repair of UVA-induced elastic fiber and collagen damage by 0.05% retinaldehyde cream in an ex vivo human skin model. Dermatology. 1999;199(Suppl 1):43–48.
07 Pechère M, et al. Antibacterial activity of retinaldehyde against Propionibacterium acnes. Dermatology. 1999;199(Suppl 1):29–31.
08 Fort-Lacoste L, et al. Comedolytic effect of topical retinaldehyde in the rhino mouse model. Dermatology. 1999;199(Suppl 1):33–35.
09 Fluhr JW, et al. Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions. Dermatology. 1999;199(Suppl 1):57–60.
10 Sachsenberg-Studer EM. Tolerance of topical retinaldehyde in humans. Dermatology. 1999;199(Suppl 1):61–63.
11 Mukherjee S, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327–348.
12 Sorg O, et al. The potential depigmenting activity of retinaldehyde. Dermatology. 2013;227(3):231–237.
13 Kwon HS, et al. Efficacy and safety of retinaldehyde 0.1% and 0.05% creams used to treat photoaged skin: a randomized double-blind controlled trial. J Cosmet Dermatol. 2018;17(3):471–476.
14 Chaudhuri RK, Bojanowski K. Bakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effects. Int J Cosmet Sci. 2014;36(3):221–230.
15 Dhaliwal S, et al. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. Br J Dermatol. 2019;180(2):289–296.
16 Brown A, et al. Natural retinol analogs potentiate the effects of retinal on aged and photodamaged skin: results from in vitro to clinical studies. Dermatol Ther (Heidelb). 2023;13(10):2299–2317.
17 Draelos ZD, et al. Clinical evaluation of a nature-based bakuchiol anti-aging moisturizer for sensitive skin. J Drugs Dermatol. 2020;19(12):1181–1183.
18 Fisher GJ, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379(6563):335–339.
19 Everts HB. Endogenous retinoids in the hair follicle and sebaceous gland. Biochim Biophys Acta. 2012;1821(1):222–229.
20 Trüeb RM. Oxidative stress in ageing of hair. Int J Trichology. 2009;1(1):6–14.

 

PuriActives® SupraFerulix™

Ferulic Acid, Reimagined:Meet PuriActives® SupraFerulix™

A supramolecular ferulic acid active for antioxidant, brightening & skin-comfort formulations.

Antioxidant protection is no longer a premium add-on — it is the new baseline.

Skincare has entered the antioxidant era. Consumers increasingly expect daily defense against oxidative stress from UV exposure, urban pollution and the visible signs of photoaging — while also asking for brighter-looking skin, sensitive-skin compatibility and microbiome-friendly care. The challenge for formulators is no longer whether to use an antioxidant, but how to deliver antioxidant performance with greater formulation flexibility and a more elegant skin experience.

01 · THE HERO MOLECULE

Why Ferulic Acid Still Matters

A classic antioxidant with enduring relevance in modern dermocosmetic and prestige skincare.

Ferulic acid · 4-hydroxy-3-methoxycinnamic acid · C10H10O4

Ferulic acid is a well-recognized plant-derived phenolic antioxidant valued for oxidative stress protection, photoaging care and radiance support. It is also known for complementing vitamin C / E antioxidant systems — one reason it remains a familiar ingredient in prestige antioxidant formulas.

Antioxidant profileHelps protect skin from environmental oxidative stress. Photoaging careSupports skin exposed to UV and environmental stress.
Radiance supportHelps improve the look of dull, tired-looking skin. Antioxidant synergyKnown for complementing vitamin C / E systems.

02 · THE FORMULATION PARADOX

Powerful, but Demanding

Conventional ferulic acid can make high-performance formulation unnecessarily difficult.

The molecule is compelling. The formulation experience can be less so. Conventional ferulic acid systems may face stability concerns, compatibility limitations, solubility and dispersibility challenges, sensory trade-offs and restricted formulation flexibility. Oxidation-driven color change, formula-environment sensitivity, uneven incorporation, and odor or color impact can all compromise the elegance of a finished product.

The market needs ferulic acid that is easier to formulate — and kinder to skin.

03 · THE PURIPHARM SOLUTION

Not Just an Ingredient. A Smart Active System.

Supramolecular association — designed, not simply mixed.

PuriActives® SupraFerulix™ · supramolecular ferulic acid active

PuriActives® SupraFerulix™ combines ferulic acid with zinc glycinate, xyloglucan and alpha-glucan oligosaccharide in a supramolecular design engineered for formulation flexibility and skin comfort.

FA Ferulic AcidAntioxidant, anti-photoaging and radiance support — the hero of the system.
ZG Zinc GlycinateSkin comfort, oil-prone skin support and soothing positioning.
XG XyloglucanBio-polymer film-forming, barrier support and a hydration-friendly skin feel.
AGO Alpha-Glucan OligosaccharidePrebiotic-inspired microbiome balance and sensitive-skin care positioning.

04 · SUPRAMOLECULAR DESIGN

A Protective Matrix, Built Around the Active

Four components work together through non-covalent supramolecular interactions.

Rather than treating ferulic acid as a stand-alone molecule, SupraFerulix™ places it within a supportive matrix. The design concept is intended to create a more formulation-friendly environment around the active, while integrating comfort-, barrier- and microbiome-oriented components into the same system.

Non-Covalent AssociationComponents work together through supramolecular interactions, not simple mixing. A Protective EnvironmentThe supportive matrix positions ferulic acid for more formulation-friendly use.
Comfort-Oriented DesignBuilt for gentle, high-performance daily skincare concepts. One Synergistic SystemAntioxidant performance is paired with comfort, barrier and microbiome positioning.

05 · FOUR PATHS TO BETTER SKIN

Performance That Goes Beyond Antioxidant Defense

A multi-dimensional skincare story for modern daily-care concepts.

Antioxidant DefenseHelps protect skin from environmental oxidative stress — UV, pollution and daily aggressors. Barrier SupportA bio-polymer film helps support the moisture barrier and a hydrated skin feel.
Skin ComfortSoothing-oriented design for daily, gentle, high-performance use. Microbiome BalancePrebiotic-inspired care designed to respect skin’s natural flora.

Xyloglucan supports a smooth, cushiony, hydration-friendly sensory concept.

06 · COMPONENT SPOTLIGHT

Four Roles, One Formula Story

Ferulic Acid is the hero antioxidant: it supports environmental stress defense, radiance and visible photoaging care, while complementing vitamin C / E systems.

Zinc Glycinate brings a mild zinc–amino acid complex into the system, supporting skin-comfort, soothing, sensitive-skin and oil-prone skin positioning.

Xyloglucan is the bio-polymer element. It forms a soft, breathable film, supports moisture retention and barrier function, and contributes to an elegant hydrated skin feel.

Alpha-Glucan Oligosaccharide adds a prebiotic-inspired angle, supporting microbiome-friendly, balance-focused and gentle daily-care concepts.

07 · FORMULATION ADVANTAGES

Designed to Formulate Beautifully

One active system, compatible with a wide range of dosage forms.

Formulation science in practice · illustration from the product presentation

Better CompatibilityImproved formulation compatibility versus conventional ferulic acid systems. Flexible Across SystemsSuitable for both water-based and emulsion-based formulations.
Elegant Skin FeelA smooth, comfortable sensory profile for prestige positioning. Clean-Beauty ReadyFits modern clean and minimalist formula concepts.
Sensitive-Skin ConceptsComfort-oriented design for gentle, sensitive-skin positioning. Dosage-Form FreedomSerums · essences · lotions · creams · masks · ampoules.

08 · READY-TO-DEVELOP CONCEPTS

Seven Product Stories From One Active System

01 Antioxidant Brightening SerumA daily radiance-and-defense hero serum.
02 Urban Defense EssenceLightweight daily shield against pollution stress.
03 Sensitive-Skin Radiance AmpouleGentle glow in an intensive, comfort-first format.
04 Anti-Photoaging CreamDaily defense against visible signs of photoaging.
05 Post-Sun Repair LotionAfter-sun comfort and antioxidant care.
06 Oil-Prone Antioxidant GelLight, balancing antioxidant care for oil-prone skin.
07 Microbiome-Friendly Daily CareEveryday moisturizer supporting skin’s natural balance.

Antioxidant brightening serum · concept visual

09 · WHY UPGRADE

Conventional Ferulic Acid vs. SupraFerulix™

Dimension Conventional Ferulic Acid PuriActives® SupraFerulix™
System design Single antioxidant molecule Supramolecular active system
Formulation Limited flexibility; stability and color-change concerns Formulation-friendly design for modern systems
Care concept Active-only approach Antioxidant + comfort + barrier + microbiome concept
Positioning Classic antioxidant Modern, skin-comfort-oriented active system

SupraFerulix™ advantages reflect design intent; detailed performance should be confirmed against PuriPharm technical data.

10 · CLAIMS & SUPPORT

A Communication Platform Built for Cosmetic Formulation

Claim DirectionHelps protect skin from oxidative stress. Claim DirectionSupports brighter-looking skin.
Claim DirectionHelps improve dull-looking complexion. Claim DirectionSupports skin comfort.
Claim DirectionMicrobiome-friendly antioxidant system. Claim DirectionDesigned for sensitive-skin-compatible antioxidant formulations.

Final claims should be validated against the regulatory requirements of each target market.

Documentation and technical support accompany the product.

Every batch is backed by complete documentation: TDS, COA, SDS, product specification, formulation guidance, regulatory support for target markets and customized technical communication on request.

Ferulic acid, reimagined as a modern supramolecular active system. PuriActives® SupraFerulix™ turns a classic antioxidant into a high-performance, skin-comfort-oriented system for antioxidant, brightening and gentle daily-care formulations.

ANTIOXIDANT DEFENSE · SKIN COMFORT · FORMULATION FREEDOM

PuriPharm Co., Ltd.

www.puriactives.comservice@puripharm.com · +86-572-2745768Building 6, No. 1366 Hongfeng Road, Huzhou, Zhejiang, China

For cosmetic formulation use only. No drug claims intended.

DECARBOXYLATED CARNOSINE

EXECUTIVE SUMMARY

WHY GLYCATION MATTERS

SKIN AGING IS MULTI-FACTORIAL

INGREDIENT BACKGROUND

MECHANISM OVERVIEW

ANTI-GLYCATION MECHANISM

CARBONYL STRESS PROTECTION

ANTIOXIDANT PROTECTION

COLLAGEN & ELASTIN PROTECTION

VISIBLE SKIN BENEFITS

DIFFERENTIATION FROM CARNOSINE

PRODUCT FORM & FORMULATION ADVANTAGES

TECHNICAL SPECIFICATIONS

RECOMMENDED APPLICATIONS

FORMULATION GUIDANCE

SYNERGY OPPORTUNITIES

MARKET POSITIONING

CLAIM LANGUAGE SUGGESTIONS

FORMULATION EXAMPLE — ANTI-GLYCATION SERUM

FORMULATION EXAMPLE — URBAN DEFENSE ESSENCE

QUALITY, STORAGE & HANDLING

WHY CHOOSE PURIPHARM

SUMMARY

PURIACTIVES® SODIUM TREHALOSE SULFATE

Product Identity & Chemistry

PuriActives®SODIUM TREHALOSE SULFATE is a low-molecular-weight sulfated disaccharide derived from trehalose. Its unique sulfation and small size (<1000 Da) enable penetration of the healthy stratum corneum.

Key Specifications

 

Multi-Target Skin Barrier Repair

 

Clinical Evidence

 

Formulation Guidelines

 

Application Matrix & Concepts

 
 

Regulatory Status & Safety

Product Data Sheet: NanoActive® Bakuchiol

1. Product Description

NanoActive® Bakuchiol is a premium, biomimetic active ingredient concept featuring highly concentrated Bakuchiol encapsulated within a proprietary sub-micron lipid nanocarrier system. Derived from the seeds of Psoralea corylifolia, this retinol-like botanical active is engineered for enhanced stability, superior aqueous dispersion, and high tolerability in modern anti-aging, sensitive-skin, and blemish-care applications.

2. INCI Name & Composition

  • INCI Name: Water (Aqua), Glycerin, Bakuchiol, Phospholipids, Caprylic/Capric Triglyceride.
  • Source: 100% Plant-derived active (Bakuchiol).
  • Solubility: Highly miscible in water-based phases; easily incorporated into aqueous serums, hydrogels, and O/W emulsions.

3. Chemical-Physical & Microbiological Specifications

Designed to meet stringent global quality standards, ensuring optimal safety and formulation elegance.

4. Key Technical Advantages

  • Retinol-like Efficacy: Acts on the same biological pathways as retinol (e.g., retinoic acid receptor signaling) without the associated irritation or light sensitivity.
  • Aqueous Transparency: The glycerin-water nanocarrier base allows the formulation of crystal-clear serums without the need for harsh solubilizers.
  • Advanced Nano-Delivery: NanoActive® encapsulation ensures controlled, sustained delivery of the 10% active payload deep into the epidermal layers.
  • Skin Barrier Support: Integrated phospholipid bilayer mimics skin lipids, reinforcing the barrier function while delivering the active.

5. Clinical Evidence Highlights

  • Anti-Aging: Supports significant reduction in the appearance of fine lines and wrinkles.
  • Firmness & Elasticity: Promotes the appearance of a firmer skin texture by supporting collagen I, III, and IV expression.
  • Soothing & Inflammation: Effectively supports the reduction of visible redness and inflammation in sensitive and acne-prone skin.
  • Pigmentation: Helps achieve a more uniform skin tone and brightness through the modulation of pigment-related pathways.

6. Formulation Guidelines

  • Recommended Use Level: 1.0% – 5.0% (delivering 0.1% – 0.5% pure Bakuchiol to the final product).
  • Processing:
  • Phase: Add into the water phase or during the final cool-down phase (below 45°C) to maintain the integrity of the nanocarrier system.
  • pH Stability: Optimal range 4.5 – 7.0.
  • Antioxidant Protection: Since the delivery system relies on an aqueous/glycerin base, adding complementary antioxidants (e.g., Vitamin E, stabilized Vitamin C) to the final formulation is highly recommended to protect the active from long-term oxidation.
  • Chelating Agents: EDTA or naturally derived chelators (e.g., Sodium Phytate) are recommended to ensure formula stability.

7. Safety & Regulatory

  • Safety Profile: High tolerability demonstrated in clinical use; suitable for sensitive skin. Non-phototoxic.
  • Claims: Supports acne-prone skin care, helps improve the appearance of blemish-prone skin, promotes clearer-looking skin, anti-aging, skin soothing.
  • Storage: Store in a cool, dry place, protected from direct light and heat. Keep container tightly closed.

8. Applications

  • Premium Anti-Aging Clear Serums & Hydrogels
  • Sensitive Skin Repair Formulations
  • Blemish-Care & Acne-Prone Skin Treatments
  • Brightening & Uneven Tone Correctors
  • Daytime Protective Skincare (Non-light-sensitizing)

Disclaimer: This document is for informational purposes for professional cosmetic formulators. The claims presented are cosmetic in nature and should be substantiated by final product testing.

NANOACTIVE ENOXOLONE PuriActives Core Molecule x NanoActive Delivery

PuriPharm: Dual Pillars of Innovation

Two Core Innovation Pillars

PuriActives: Enoxolone from Licorice Root

NanoActive NanoCarrier: Delivery Architecture

Application Challenges: Enoxolone Limitations

NanoActive System Solution

NanoActive Enoxolone = PuriActives Molecule + NanoActive Technology

Through nano-encapsulation, insoluble crystalline powder becomes a clear, transparent, stable bioactive liquid. We deliver precision-calculated efficacy.

NanoActive Parameters: Size Advantage

Product Technical Specifications

NanoActive Drives Deep Penetration

Multi-dimensional Efficacy

Anti-inflammatory Power: TSLP Inhibition

Clinical Evidence: Atopic Dermatitis Relief

NanoActive Antioxidant Defense Matrix

11β-HSD1 Inhibition: Correcting Steroid Skin

Antimicrobial Activity

Skin Barrier Repair & Soothing

Formulation Application Guide